APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Nutritional Product

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Intravenous Nutritional Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025190 pages

Choose your research edition.

Industry ResearchIntravenous Nutritional Product Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Nutritional Product Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Intravenous Nutritional Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Nutritional Product Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Nutritional Product Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Intravenous Nutritional Product market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Intravenous Nutritional Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Intravenous Nutritional Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intravenous Nutritional Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Intravenous Nutritional Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Intravenous Nutritional Product include Xi'an Libang Pharmaceutical, Weixinkang, B. Braun, Baxter, Otsuka Pharmaceutical, Lummy, Lionco Pharmaceutical, King York and Kelun Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Intravenous Nutritional Product market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Intravenous Nutritional Product and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Intravenous Nutritional Product revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Intravenous Nutritional Product market size, projected growth trends, production technologies, key applications, and end-use industries.

Intravenous Nutritional Product Segment by Company

Xi'an Libang Pharmaceutical

Weixinkang

B. Braun

Baxter

Otsuka Pharmaceutical

Lummy

Lionco Pharmaceutical

King York

Kelun Pharma

JW Pharmaceutical

Haisco Pharmaceutical Group

Grifols

Grand Life Sciences

Fresenius Kabi

Cisen

China Meheco Kangli

Biokin Pharmaceutical

BBCA Pharmaceutical

Baizheng Pharmaceutical

Aguettant

Intravenous Nutritional Product Segment by Type

Amino Acid

Alanyl-Glutamine

Heat and Fat Emulsion

Trace Elements

Vitamins

Intravenous Nutritional Product Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Others

Intravenous Nutritional Product Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Nutritional Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Nutritional Product and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Nutritional Product.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Intravenous Nutritional Product in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Intravenous Nutritional Product industry.

Chapter 3: Detailed analysis of Intravenous Nutritional Product companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intravenous Nutritional Productrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Intravenous Nutritional Product Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Amino Acid Table 3. Key Players of Alanyl-Glutamine Table 4. Key Players of Heat and Fat Emulsion Table 3. Key Players of Trace Elements Table 4. Key Players of Vitamins Table 5. Global Intravenous Nutritional Product Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Hospital Pharmacies Table 7. Key Players of Online Pharmacies Table 8. Key Players of Retail Pharmacies Table 9. Key Players of Others Table 10. Global Intravenous Nutritional Product Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Intravenous Nutritional Product Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Intravenous Nutritional Product Market Share by Region (2021-2026) Table 13. Global Intravenous Nutritional Product Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Intravenous Nutritional Product Market Share by Region (2027-2032) Table 15. Intravenous Nutritional Product Industry Trends Table 16. Intravenous Nutritional Product Industry Drivers Table 17. Intravenous Nutritional Product Industry Opportunities and Challenges Table 18. Intravenous Nutritional Product Industry Restraints Table 19. Global Intravenous Nutritional Product Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Intravenous Nutritional Product Revenue Market Share by Company (2021-2026) Table 21. Global Intravenous Nutritional Product Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Intravenous Nutritional Product Key Company Head Office and Area Served Table 23. Global Intravenous Nutritional Product Company, Product Type & Application Table 24. Global Intravenous Nutritional Product Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Intravenous Nutritional Product by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Intravenous Nutritional Product Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Intravenous Nutritional Product Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Intravenous Nutritional Product Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Intravenous Nutritional Product Revenue Market Share by Type (2021-2026) Table 31. Global Intravenous Nutritional Product Revenue Market Share by Type (2027-2032) Table 32. Global Intravenous Nutritional Product Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Intravenous Nutritional Product Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Intravenous Nutritional Product Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Intravenous Nutritional Product Revenue Market Share by Application (2021-2026) Table 36. Global Intravenous Nutritional Product Revenue Market Share by Application (2027-2032) Table 37. Xi'an Libang Pharmaceutical Company Information Table 38. Xi'an Libang Pharmaceutical Business Overview Table 39. Xi'an Libang Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Xi'an Libang Pharmaceutical Intravenous Nutritional Product Product Portfolio Table 41. Xi'an Libang Pharmaceutical Recent Development Table 42. Weixinkang Company Information Table 43. Weixinkang Business Overview Table 44. Weixinkang Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Weixinkang Intravenous Nutritional Product Product Portfolio Table 46. Weixinkang Recent Development Table 47. B. Braun Company Information Table 48. B. Braun Business Overview Table 49. B. Braun Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. B. Braun Intravenous Nutritional Product Product Portfolio Table 51. B. Braun Recent Development Table 52. Baxter Company Information Table 53. Baxter Business Overview Table 54. Baxter Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Baxter Intravenous Nutritional Product Product Portfolio Table 56. Baxter Recent Development Table 57. Otsuka Pharmaceutical Company Information Table 58. Otsuka Pharmaceutical Business Overview Table 59. Otsuka Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Otsuka Pharmaceutical Intravenous Nutritional Product Product Portfolio Table 61. Otsuka Pharmaceutical Recent Development Table 62. Lummy Company Information Table 63. Lummy Business Overview Table 64. Lummy Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Lummy Intravenous Nutritional Product Product Portfolio Table 66. Lummy Recent Development Table 67. Lionco Pharmaceutical Company Information Table 68. Lionco Pharmaceutical Business Overview Table 69. Lionco Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Lionco Pharmaceutical Intravenous Nutritional Product Product Portfolio Table 71. Lionco Pharmaceutical Recent Development Table 72. King York Company Information Table 73. King York Business Overview Table 74. King York Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. King York Intravenous Nutritional Product Product Portfolio Table 76. King York Recent Development Table 77. Kelun Pharma Company Information Table 78. Kelun Pharma Business Overview Table 79. Kelun Pharma Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Kelun Pharma Intravenous Nutritional Product Product Portfolio Table 81. Kelun Pharma Recent Development Table 82. JW Pharmaceutical Company Information Table 83. JW Pharmaceutical Business Overview Table 84. JW Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. JW Pharmaceutical Intravenous Nutritional Product Product Portfolio Table 86. JW Pharmaceutical Recent Development Table 87. Haisco Pharmaceutical Group Company Information Table 88. Haisco Pharmaceutical Group Business Overview Table 89. Haisco Pharmaceutical Group Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Haisco Pharmaceutical Group Intravenous Nutritional Product Product Portfolio Table 91. Haisco Pharmaceutical Group Recent Development Table 92. Grifols Company Information Table 93. Grifols Business Overview Table 94. Grifols Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Grifols Intravenous Nutritional Product Product Portfolio Table 96. Grifols Recent Development Table 97. Grand Life Sciences Company Information Table 98. Grand Life Sciences Business Overview Table 99. Grand Life Sciences Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. Grand Life Sciences Intravenous Nutritional Product Product Portfolio Table 101. Grand Life Sciences Recent Development Table 102. Fresenius Kabi Company Information Table 103. Fresenius Kabi Business Overview Table 104. Fresenius Kabi Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. Fresenius Kabi Intravenous Nutritional Product Product Portfolio Table 106. Fresenius Kabi Recent Development Table 107. Cisen Company Information Table 108. Cisen Business Overview Table 109. Cisen Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 110. Cisen Intravenous Nutritional Product Product Portfolio Table 111. Cisen Recent Development Table 112. China Meheco Kangli Company Information Table 113. China Meheco Kangli Business Overview Table 114. China Meheco Kangli Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 115. China Meheco Kangli Intravenous Nutritional Product Product Portfolio Table 116. China Meheco Kangli Recent Development Table 117. Biokin Pharmaceutical Company Information Table 118. Biokin Pharmaceutical Business Overview Table 119. Biokin Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 120. Biokin Pharmaceutical Intravenous Nutritional Product Product Portfolio Table 121. Biokin Pharmaceutical Recent Development Table 122. BBCA Pharmaceutical Company Information Table 123. BBCA Pharmaceutical Business Overview Table 124. BBCA Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 125. BBCA Pharmaceutical Intravenous Nutritional Product Product Portfolio Table 126. BBCA Pharmaceutical Recent Development Table 127. Baizheng Pharmaceutical Company Information Table 128. Baizheng Pharmaceutical Business Overview Table 129. Baizheng Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 130. Baizheng Pharmaceutical Intravenous Nutritional Product Product Portfolio Table 131. Baizheng Pharmaceutical Recent Development Table 132. Aguettant Company Information Table 133. Aguettant Business Overview Table 134. Aguettant Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 135. Aguettant Intravenous Nutritional Product Product Portfolio Table 136. Aguettant Recent Development Table 137. North America Intravenous Nutritional Product Market Size by Type (2021-2026) & (US$ Million) Table 138. North America Intravenous Nutritional Product Market Size by Type (2027-2032) & (US$ Million) Table 139. North America Intravenous Nutritional Product Market Size by Application (2021-2026) & (US$ Million) Table 140. North America Intravenous Nutritional Product Market Size by Application (2027-2032) & (US$ Million) Table 141. North America Intravenous Nutritional Product Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. North America Intravenous Nutritional Product Market Size by Country (2021-2026) Table 143. North America Intravenous Nutritional Product Market Size by Country (2027-2032) Table 144. Europe Intravenous Nutritional Product Market Size by Type (2021-2026) & (US$ Million) Table 145. Europe Intravenous Nutritional Product Market Size by Type (2027-2032) & (US$ Million) Table 146. Europe Intravenous Nutritional Product Market Size by Application (2021-2026) & (US$ Million) Table 147. Europe Intravenous Nutritional Product Market Size by Application (2027-2032) & (US$ Million) Table 148. Europe Intravenous Nutritional Product Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Europe Intravenous Nutritional Product Market Size by Country (2021-2026) Table 150. Europe Intravenous Nutritional Product Market Size by Country (2027-2032) Table 151. China Intravenous Nutritional Product Market Size by Type (2021-2026) & (US$ Million) Table 152. China Intravenous Nutritional Product Market Size by Type (2027-2032) & (US$ Million) Table 153. China Intravenous Nutritional Product Market Size by Application (2021-2026) & (US$ Million) Table 154. China Intravenous Nutritional Product Market Size by Application (2027-2032) & (US$ Million) Table 155. Asia Intravenous Nutritional Product Market Size by Type (2021-2026) & (US$ Million) Table 156. Asia Intravenous Nutritional Product Market Size by Type (2027-2032) & (US$ Million) Table 157. Asia Intravenous Nutritional Product Market Size by Application (2021-2026) & (US$ Million) Table 158. Asia Intravenous Nutritional Product Market Size by Application (2027-2032) & (US$ Million) Table 159. Asia Intravenous Nutritional Product Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Intravenous Nutritional Product Market Size by Country (2021-2026) Table 161. Asia Intravenous Nutritional Product Market Size by Country (2027-2032) Table 162. South America, Middle East & Africa Intravenous Nutritional Product Market Size by Type (2021-2026) & (US$ Million) Table 163. South America, Middle East & Africa Intravenous Nutritional Product Market Size by Type (2027-2032) & (US$ Million) Table 164. South America, Middle East & Africa Intravenous Nutritional Product Market Size by Application (2021-2026) & (US$ Million) Table 165. South America, Middle East & Africa Intravenous Nutritional Product Market Size by Application (2027-2032) & (US$ Million) Table 166. South America, Middle East & Africa Intravenous Nutritional Product Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. South America, Middle East & Africa Intravenous Nutritional Product Market Size by Country (2021-2026) Table 168. South America, Middle East & Africa Intravenous Nutritional Product Market Size by Country (2027-2032) Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Intravenous Nutritional Product Product Image Figure 2. Global Intravenous Nutritional Product Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Intravenous Nutritional Product Market Share by Type: 2025 VS 2032 Figure 4. Amino Acid Image Figure 5. Alanyl-Glutamine Image Figure 6. Heat and Fat Emulsion Image Figure 7. Trace Elements Image Figure 8. Vitamins Image Figure 9. Global Intravenous Nutritional Product Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Intravenous Nutritional Product Market Share by Application: 2025 VS 2032 Figure 11. Hospital Pharmacies Image Figure 12. Online Pharmacies Image Figure 13. Retail Pharmacies Image Figure 14. Others Image Figure 15. Global Intravenous Nutritional Product Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 17. Global Intravenous Nutritional Product Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Intravenous Nutritional Product Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Intravenous Nutritional Product Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Intravenous Nutritional Product Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Intravenous Nutritional Product Revenue Market Share by Type (2021-2032) Figure 24. Global Intravenous Nutritional Product Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Intravenous Nutritional Product Revenue Market Share by Application (2021-2032) Figure 26. North America Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 27. North America Intravenous Nutritional Product Market Share by Type (2021-2032) Figure 28. North America Intravenous Nutritional Product Market Share by Application (2021-2032) Figure 29. North America Intravenous Nutritional Product Market Share by Country (2021-2032) Figure 30. United States Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 31. Canada Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 33. Europe Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 34. Europe Intravenous Nutritional Product Market Share by Type (2021-2032) Figure 35. Europe Intravenous Nutritional Product Market Share by Application (2021-2032) Figure 36. Europe Intravenous Nutritional Product Market Share by Country (2021-2032) Figure 37. Germany Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 38. France Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 40. Italy Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 41. Russia Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 43. China Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 44. China Intravenous Nutritional Product Market Share by Type (2021-2032) Figure 45. China Intravenous Nutritional Product Market Share by Application (2021-2032) Figure 46. Asia Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 47. Asia Intravenous Nutritional Product Market Share by Type (2021-2032) Figure 48. Asia Intravenous Nutritional Product Market Share by Application (2021-2032) Figure 49. Asia Intravenous Nutritional Product Market Share by Country (2021-2032) Figure 50. Japan Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 54. India Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 55. Australia Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Intravenous Nutritional Product Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Intravenous Nutritional Product Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Intravenous Nutritional Product Market Share by Country (2021-2032) Figure 60. Brazil Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 65. UAE Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 67. Chile Intravenous Nutritional Product Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Amino Acid
  • Alanyl-Glutamine
  • Heat and Fat Emulsion
  • Trace Elements
  • Vitamins
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Others
Companies covered
  • Xi'an Libang Pharmaceutical
  • Weixinkang
  • B. Braun
  • Baxter
  • Otsuka Pharmaceutical
  • Lummy
  • Lionco Pharmaceutical
  • King York
  • Kelun Pharma
  • JW Pharmaceutical
  • Haisco Pharmaceutical Group
  • Grifols
  • Grand Life Sciences
  • Fresenius Kabi
  • Cisen
  • China Meheco Kangli
  • Biokin Pharmaceutical
  • BBCA Pharmaceutical
  • Baizheng Pharmaceutical
  • Aguettant

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Intravenous Nutritional Product Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Amino Acid
  5. 1.2.3 Alanyl-Glutamine
  6. 1.2.4 Heat and Fat Emulsion
  7. 1.2.5 Trace Elements
  8. 1.2.6 Vitamins
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Intravenous Nutritional Product Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital Pharmacies
  12. 1.3.3 Online Pharmacies
  13. 1.3.4 Retail Pharmacies
  14. 1.3.5 Others
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Intravenous Nutritional Product Growth Trends by Region
  17. 1.5.1 Global Intravenous Nutritional Product Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Intravenous Nutritional Product Market Size by Region (2021-2026)
  19. 1.5.3 Intravenous Nutritional Product Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Intravenous Nutritional Product Market Dynamics
  1. 2.1 Intravenous Nutritional Product Industry Trends
  2. 2.2 Intravenous Nutritional Product Industry Drivers
  3. 2.3 Intravenous Nutritional Product Industry Opportunities and Challenges
  4. 2.4 Intravenous Nutritional Product Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Intravenous Nutritional Product Revenue by Company (2021-2026)
  2. 3.2 Global Intravenous Nutritional Product Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Intravenous Nutritional Product Key Company Head office and Area Served
  4. 3.4 Global Intravenous Nutritional Product Company, Product Type & Application
  5. 3.5 Global Intravenous Nutritional Product Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Intravenous Nutritional Product Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Intravenous Nutritional Product Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Intravenous Nutritional Product Tier 1, Tier 2, and Tier 3
4 Intravenous Nutritional Product Market by Type
  1. 4.1 Global Intravenous Nutritional Product Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Intravenous Nutritional Product Market Size by Type (2021-2032)
  3. 4.3 Global Intravenous Nutritional Product Market Size Share by Type (2021-2032)
5 Intravenous Nutritional Product Market by Application
  1. 5.1 Global Intravenous Nutritional Product Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Intravenous Nutritional Product Market Size by Application (2021-2032)
  3. 5.3 Global Intravenous Nutritional Product Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Xi'an Libang Pharmaceutical
  2. 6.1.1 Xi'an Libang Pharmaceutical Company Information
  3. 6.1.2 Xi'an Libang Pharmaceutical Business Overview
  4. 6.1.3 Xi'an Libang Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Xi'an Libang Pharmaceutical Intravenous Nutritional Product Product Portfolio
  6. 6.1.5 Xi'an Libang Pharmaceutical Recent Developments
  7. 6.2 Weixinkang
  8. 6.2.1 Weixinkang Company Information
  9. 6.2.2 Weixinkang Business Overview
  10. 6.2.3 Weixinkang Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Weixinkang Intravenous Nutritional Product Product Portfolio
  12. 6.2.5 Weixinkang Recent Developments
  13. 6.3 B. Braun
  14. 6.3.1 B. Braun Company Information
  15. 6.3.2 B. Braun Business Overview
  16. 6.3.3 B. Braun Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 B. Braun Intravenous Nutritional Product Product Portfolio
  18. 6.3.5 B. Braun Recent Developments
  19. 6.4 Baxter
  20. 6.4.1 Baxter Company Information
  21. 6.4.2 Baxter Business Overview
  22. 6.4.3 Baxter Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Baxter Intravenous Nutritional Product Product Portfolio
  24. 6.4.5 Baxter Recent Developments
  25. 6.5 Otsuka Pharmaceutical
  26. 6.5.1 Otsuka Pharmaceutical Company Information
  27. 6.5.2 Otsuka Pharmaceutical Business Overview
  28. 6.5.3 Otsuka Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Otsuka Pharmaceutical Intravenous Nutritional Product Product Portfolio
  30. 6.5.5 Otsuka Pharmaceutical Recent Developments
  31. 6.6 Lummy
  32. 6.6.1 Lummy Company Information
  33. 6.6.2 Lummy Business Overview
  34. 6.6.3 Lummy Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Lummy Intravenous Nutritional Product Product Portfolio
  36. 6.6.5 Lummy Recent Developments
  37. 6.7 Lionco Pharmaceutical
  38. 6.7.1 Lionco Pharmaceutical Company Information
  39. 6.7.2 Lionco Pharmaceutical Business Overview
  40. 6.7.3 Lionco Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Lionco Pharmaceutical Intravenous Nutritional Product Product Portfolio
  42. 6.7.5 Lionco Pharmaceutical Recent Developments
  43. 6.8 King York
  44. 6.8.1 King York Company Information
  45. 6.8.2 King York Business Overview
  46. 6.8.3 King York Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 King York Intravenous Nutritional Product Product Portfolio
  48. 6.8.5 King York Recent Developments
  49. 6.9 Kelun Pharma
  50. 6.9.1 Kelun Pharma Company Information
  51. 6.9.2 Kelun Pharma Business Overview
  52. 6.9.3 Kelun Pharma Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Kelun Pharma Intravenous Nutritional Product Product Portfolio
  54. 6.9.5 Kelun Pharma Recent Developments
  55. 6.10 JW Pharmaceutical
  56. 6.10.1 JW Pharmaceutical Company Information
  57. 6.10.2 JW Pharmaceutical Business Overview
  58. 6.10.3 JW Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 JW Pharmaceutical Intravenous Nutritional Product Product Portfolio
  60. 6.10.5 JW Pharmaceutical Recent Developments
  61. 6.11 Haisco Pharmaceutical Group
  62. 6.11.1 Haisco Pharmaceutical Group Company Information
  63. 6.11.2 Haisco Pharmaceutical Group Business Overview
  64. 6.11.3 Haisco Pharmaceutical Group Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Haisco Pharmaceutical Group Intravenous Nutritional Product Product Portfolio
  66. 6.11.5 Haisco Pharmaceutical Group Recent Developments
  67. 6.12 Grifols
  68. 6.12.1 Grifols Company Information
  69. 6.12.2 Grifols Business Overview
  70. 6.12.3 Grifols Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Grifols Intravenous Nutritional Product Product Portfolio
  72. 6.12.5 Grifols Recent Developments
  73. 6.13 Grand Life Sciences
  74. 6.13.1 Grand Life Sciences Company Information
  75. 6.13.2 Grand Life Sciences Business Overview
  76. 6.13.3 Grand Life Sciences Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Grand Life Sciences Intravenous Nutritional Product Product Portfolio
  78. 6.13.5 Grand Life Sciences Recent Developments
  79. 6.14 Fresenius Kabi
  80. 6.14.1 Fresenius Kabi Company Information
  81. 6.14.2 Fresenius Kabi Business Overview
  82. 6.14.3 Fresenius Kabi Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Fresenius Kabi Intravenous Nutritional Product Product Portfolio
  84. 6.14.5 Fresenius Kabi Recent Developments
  85. 6.15 Cisen
  86. 6.15.1 Cisen Company Information
  87. 6.15.2 Cisen Business Overview
  88. 6.15.3 Cisen Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Cisen Intravenous Nutritional Product Product Portfolio
  90. 6.15.5 Cisen Recent Developments
  91. 6.16 China Meheco Kangli
  92. 6.16.1 China Meheco Kangli Company Information
  93. 6.16.2 China Meheco Kangli Business Overview
  94. 6.16.3 China Meheco Kangli Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 China Meheco Kangli Intravenous Nutritional Product Product Portfolio
  96. 6.16.5 China Meheco Kangli Recent Developments
  97. 6.17 Biokin Pharmaceutical
  98. 6.17.1 Biokin Pharmaceutical Company Information
  99. 6.17.2 Biokin Pharmaceutical Business Overview
  100. 6.17.3 Biokin Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Biokin Pharmaceutical Intravenous Nutritional Product Product Portfolio
  102. 6.17.5 Biokin Pharmaceutical Recent Developments
  103. 6.18 BBCA Pharmaceutical
  104. 6.18.1 BBCA Pharmaceutical Company Information
  105. 6.18.2 BBCA Pharmaceutical Business Overview
  106. 6.18.3 BBCA Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 BBCA Pharmaceutical Intravenous Nutritional Product Product Portfolio
  108. 6.18.5 BBCA Pharmaceutical Recent Developments
  109. 6.19 Baizheng Pharmaceutical
  110. 6.19.1 Baizheng Pharmaceutical Company Information
  111. 6.19.2 Baizheng Pharmaceutical Business Overview
  112. 6.19.3 Baizheng Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Baizheng Pharmaceutical Intravenous Nutritional Product Product Portfolio
  114. 6.19.5 Baizheng Pharmaceutical Recent Developments
  115. 6.20 Aguettant
  116. 6.20.1 Aguettant Company Information
  117. 6.20.2 Aguettant Business Overview
  118. 6.20.3 Aguettant Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Aguettant Intravenous Nutritional Product Product Portfolio
  120. 6.20.5 Aguettant Recent Developments
7 North America
  1. 7.1 North America Intravenous Nutritional Product Market Size (2021-2032)
  2. 7.2 North America Intravenous Nutritional Product Market Size by Type
  3. 7.2.1 North America Intravenous Nutritional Product Market Size by Type (2021-2026)
  4. 7.2.2 North America Intravenous Nutritional Product Market Size by Type (2027-2032)
  5. 7.2.3 North America Intravenous Nutritional Product Market Share by Type (2021-2032)
  6. 7.3 North America Intravenous Nutritional Product Market Size by Application
  7. 7.3.1 North America Intravenous Nutritional Product Market Size by Application (2021-2026)
  8. 7.3.2 North America Intravenous Nutritional Product Market Size by Application (2027-2032)
  9. 7.3.3 North America Intravenous Nutritional Product Market Share by Application (2021-2032)
  10. 7.4 North America Intravenous Nutritional Product Market Size by Country
  11. 7.4.1 North America Intravenous Nutritional Product Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Intravenous Nutritional Product Market Size by Country (2021-2026)
  13. 7.4.3 North America Intravenous Nutritional Product Market Size by Country (2027-2032)
  14. 7.4.4 North America Intravenous Nutritional Product Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Intravenous Nutritional Product Market Size (2021-2032)
  2. 8.2 Europe Intravenous Nutritional Product Market Size by Type
  3. 8.2.1 Europe Intravenous Nutritional Product Market Size by Type (2021-2026)
  4. 8.2.2 Europe Intravenous Nutritional Product Market Size by Type (2027-2032)
  5. 8.2.3 Europe Intravenous Nutritional Product Market Share by Type (2021-2032)
  6. 8.3 Europe Intravenous Nutritional Product Market Size by Application
  7. 8.3.1 Europe Intravenous Nutritional Product Market Size by Application (2021-2026)
  8. 8.3.2 Europe Intravenous Nutritional Product Market Size by Application (2027-2032)
  9. 8.3.3 Europe Intravenous Nutritional Product Market Share by Application (2021-2032)
  10. 8.4 Europe Intravenous Nutritional Product Market Size by Country
  11. 8.4.1 Europe Intravenous Nutritional Product Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Intravenous Nutritional Product Market Size by Country (2021-2026)
  13. 8.4.3 Europe Intravenous Nutritional Product Market Size by Country (2027-2032)
  14. 8.4.4 Europe Intravenous Nutritional Product Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Intravenous Nutritional Product Market Size (2021-2032)
  2. 9.2 China Intravenous Nutritional Product Market Size by Type
  3. 9.2.1 China Intravenous Nutritional Product Market Size by Type (2021-2026)
  4. 9.2.2 China Intravenous Nutritional Product Market Size by Type (2027-2032)
  5. 9.2.3 China Intravenous Nutritional Product Market Share by Type (2021-2032)
  6. 9.3 China Intravenous Nutritional Product Market Size by Application
  7. 9.3.1 China Intravenous Nutritional Product Market Size by Application (2021-2026)
  8. 9.3.2 China Intravenous Nutritional Product Market Size by Application (2027-2032)
  9. 9.3.3 China Intravenous Nutritional Product Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Intravenous Nutritional Product Market Size (2021-2032)
  2. 10.2 Asia Intravenous Nutritional Product Market Size by Type
  3. 10.2.1 Asia Intravenous Nutritional Product Market Size by Type (2021-2026)
  4. 10.2.2 Asia Intravenous Nutritional Product Market Size by Type (2027-2032)
  5. 10.2.3 Asia Intravenous Nutritional Product Market Share by Type (2021-2032)
  6. 10.3 Asia Intravenous Nutritional Product Market Size by Application
  7. 10.3.1 Asia Intravenous Nutritional Product Market Size by Application (2021-2026)
  8. 10.3.2 Asia Intravenous Nutritional Product Market Size by Application (2027-2032)
  9. 10.3.3 Asia Intravenous Nutritional Product Market Share by Application (2021-2032)
  10. 10.4 Asia Intravenous Nutritional Product Market Size by Country
  11. 10.4.1 Asia Intravenous Nutritional Product Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Intravenous Nutritional Product Market Size by Country (2021-2026)
  13. 10.4.3 Asia Intravenous Nutritional Product Market Size by Country (2027-2032)
  14. 10.4.4 Asia Intravenous Nutritional Product Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Intravenous Nutritional Product Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Intravenous Nutritional Product Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Intravenous Nutritional Product Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Intravenous Nutritional Product Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Intravenous Nutritional Product Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Intravenous Nutritional Product Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Intravenous Nutritional Product Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Intravenous Nutritional Product Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Intravenous Nutritional Product Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Intravenous Nutritional Product Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Intravenous Nutritional Product Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Intravenous Nutritional Product Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Intravenous Nutritional Product Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Intravenous Nutritional Product Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst